Interaction of insulin and AMPK in the ischemic heart - Another chapter in the book of metabolic therapy?

被引：22
|
作者：
Tian, Rong [1 ]
Balschi, James A. [1 ]
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med,NMR Lab Physiol Chem, Boston, MA 02115 USA
来源：
CIRCULATION RESEARCH | 2006年 / 99卷 / 01期
关键词：
insulin; AMPK; glucose; myocardial ischemia; metabolic modulation;
D O I：
10.1161/01.RES.0000233142.26369.f6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 5
页数：3
相关论文
共 31 条
  • [21] Clinical efficacy of combined therapy with enalapril plus trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances
    Petelina, TI
    Gapon, LI
    Bakhmatova, YA
    Zhevagina, IA
    TERAPEVTICHESKII ARKHIV, 2005, 77 (08) : 19 - 23
  • [22] Raised plasma concentrations of insulin-like growth factor-1 and erythropoietin in patients with ischemic heart disease and metabolic syndrome
    Lavorgna, A.
    Marzo, F.
    Coluzzi, G.
    Cecchetti, S.
    Ricerca, B.
    Carrozza, C.
    Lulli, P.
    Zuppi, C.
    Crea, F.
    Andreotti, F.
    EUROPEAN HEART JOURNAL, 2007, 28 : 341 - 341
  • [23] A defect Δ6 and Δ5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians
    Das, Undurti N.
    LIPIDS IN HEALTH AND DISEASE, 2010, 9
  • [24] A defect in Δ6 and Δ5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians
    Undurti N Das
    Lipids in Health and Disease, 9
  • [25] Raised plasma concentrations of insulin-like growth factor-1 and erythropoietin in patients with ischemic heart disease and metabolic syndrome
    Lavorgna, A.
    Cecchetti, S.
    Rio, T.
    Coluzzi, G.
    Carrozza, C.
    Conti, E.
    Crea, F.
    Andreotti, F.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S79 - S79
  • [26] The Metabolic Score for Insulin Resistance (METS-IR) as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study among Korean without Diabetes
    Yoon, Jihyun
    Jung, Donghyuk
    Lee, Yongjae
    Park, Byoungjin
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [27] Metabolic therapy for elderly patients with chronic heart failure. Effects of testosterone on oxygen uptake, insulin resistance and muscle strength
    Caminiti, G.
    Volterrani, M.
    Massaro, R.
    Marazzi, G.
    Micheletta, F.
    Arisi, A.
    Mammi, C.
    Rosano, G.
    EUROPEAN HEART JOURNAL, 2007, 28 : 387 - 387
  • [28] Increased plasma concentrations of insulin-like growth factor-1 and erythropoietin with number of metabolic syndrome components in patients with ischemic heart disease
    Lavorgna, A.
    Ceccchetti, S.
    Rio, T.
    Marzo, F.
    Carrozza, C.
    Conti, E.
    Crea, F.
    Andreotti, F.
    EUROPEAN HEART JOURNAL, 2010, 31 : 542 - 542
  • [29] Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: Insights from BARI-2D trial
    Damluji, Abdulla A.
    Cohen, Erin R.
    Moscucci, Mauro
    Myerburg, Robert J.
    Cohen, Mauricio G.
    Brooks, Maria M.
    Rich, Michael W.
    Forman, Daniel E.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 241 : 35 - 40
  • [30] INSULIN PROVISION THERAPY AND INCREASED MORTALITY IN ELDERLY PATIENTS WITH DIABETES MELLITUS AND STABLE ISCHEMIC HEART DISEASE: INSIGHTS FROM BARI-2D TRIAL
    Damluji, Abdulla
    Cohen, Erin R.
    Myerburg, Robert
    Cohen, Mauricio
    Moscucci, Mauro
    Rich, Michael
    Forman, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1592 - A1592
1234